Navigation Links
A New Study Throws Limelight in HIV Vaccine Production

The research collaborative involving scientists from the British Columbia Centre for Excellence in HIV/AIDS , Massachusetts General Hospital (MGH), Microsoft Research and Los Alamos National Laboratory used highly computer-intensive, cutting-edge statistical research methods to investigate how the HIV virus mutates to escape the bodys immune system.

A pioneering collaborative study has discovered how the HIV virus evades the human bodys immune system. Specifically, HLA class 1 is a controlling part of the human immune response. The ability of HIV to escape recognition by HLA class 1 leaves the body incapable of finding and fighting the virus.

The study, published in the July issue of PLoS Pathogens, is the largest population-based investigation of how natural variations in HLA class 1 can influence HIV genetic sequence, as well as the first characterization of changes in multiple HIV genes in response to HLA-associated evolutionary pressure.

Researchers successfully mapped sites within particular HIV genes where variations can improve the viruss ability to escape immune recognition, showing this is predictable based upon the HIV patients individual HLA class 1 profile.

This is a novel and advanced description of how the human immune system attacks the virus, and how it responds says Dr. Richard Harrigan, Director of the Centres Research Laboratories and study co-author.

While we always knew the body attacks the virus and the virus changes to dodge pressure, were now more exact in knowing how this happens in people.

While the study is valuable in helping the scientific community understand how immune pressure impacts HIV, these findings hold tremendous promise in terms of global HIV efforts, says Dr. Zabrina Brumme, the studys lead author.

Achieving a more in-depth understanding of the ways in which HIV mutates to avoid the human immune system will help with the design of
'"/>




Page: 1 2

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
(Date:12/2/2008)...Newswire-FirstCall/ -- VirtualScopics, Inc.,(Nasd...maging for clinical,trials, today announced that ...d to $14.7 million at the same time a year ago, a ... backlog as the amount remaining to be,recognized...f the studies,included within the backlog ranges ...
(Date:12/2/2008)...t Finds Many Cite Prevention, Shedding, or Sharing...swire-USNewswire/ -- A New Center for State and Lo...es are balancing retiree health care plans and the...th Care in the American States examines how state... health care benefits to central human resources (...
(Date:12/2/2008)...nts treated with radiation prior to surgery for ad...r recurrence and better overall survival rates, ac...rt examined a treatment called neoadjuvant therapy...he spread of cancer, before surgery to remove the ...y and/or radiation. , Neoadjuvant therapy shoul...
(Date:12/2/2008)...port from the Institute of Medicine proposes revis...s to decrease the chances of fatigue-related medic...for these doctors in training. The report does no... from the maximum average of 80 per week set by th...tion (ACGME) in 2003, but rather reduces the maxim...
Breaking Medicine News(10 mins):Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:States View Limits on Retiree Health Benefits 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3
... is common among older men. Being the second most ...cer, it is the second leading cause of cancer deat...tection there has been a increase in number of det...reening consists of digital rectal exam and a pros...
...HO's list that travelers should avoid because of S...fe place to live were stunned by this. Toronto is ...as a threat to international health because of the...e in China were also added to its list, which alre...
...in the UK most people believe that asthma is a con...of people with asthma develop the condition in adu... are not recognised and managed in early stages. A...ime at any age. There also exists a possibility wh...
...ound that an active lifestyle with limiting TV tim...survey conducted in the US TV watching results in ... like sewing, playing board games, reading, writin... linked to obesity in children. The health campaig...
Other Medicine News:
(Date:12/1/2008)...with Hypophosphatasia Treated With ENB-0040 at Chi...eg , , MONTREAL, Dec. 1 Eno...ocused on developing novel therapeutics for seriou...nfant patient in its clinical program for hypophos... Replacement Therapy (ERT) with ENB-0040 for the t...
(Date:12/1/2008)...ARD, Denmark, December 1 ...with the intent to procure an MVA-based,third ge...ment Services,Canada, on behalf of the Canadian D...ract to Bavarian Nordic for the delivery of IMVAMU... use IMVAMUNE(R) as part of the,country,s bio-pre...
(Date:11/30/2008)... CHICAGO, Dec. 1 Older...bral blood flow and a greater number of small bloo...ented today at the annual meeting of the Radiologi...he study, conducted at the University of North Ca...pare brain scans of older adults who exercise to b...
(Date:11/27/2008)...finds the majority of acute lymphoblastic leukemia...t the time of diagnosis , , MEMPHIS, Tenn.,...St. Jude Children,s Research Hospital have identif...s of children with acute lymphoblastic leukemia (A...ay to designing treatments for ALL relapse in chil...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3First Lady Laura Bush Visits AED Netmark Malaria Control Project in Ghana 12394 1First Lady Laura Bush Visits AED Netmark Malaria Control Project in Ghana 12394 2Sikka Software and Dental Economics Announce Alliance 12392 1Sikka Software and Dental Economics Announce Alliance 12392 2Yoga Journal Circulation Increases 5 8 Percent in Second Half of 2007 from Same Period Previous Year 12390 1Yoga Journal Circulation Increases 5 8 Percent in Second Half of 2007 from Same Period Previous Year 12390 2Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 1Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 2Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 3Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 4Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 5Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 6Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 7
...ther diagnostic regimes that were previously restr...lysis is entering the clinical mainstream. Smaller...fordable for hospital or large physicians group la...lable for primary point of care locations such as ... 310 Genetic Analyzer from Applied Biosystems, Fos...
...5, Chiron Corporation notified the CDC that none o...ble for distribution in the United States for the ...en removal of nearly half of the anticipated Ameri...ral public have grown increasingly alarmed about t...pidemic. , ,It remains to be seen if virulent ...
Other Medicine Technology:Genetic Analysis Systems Enter the Clinical Mainstream 2Genetic Analysis Systems Enter the Clinical Mainstream 3Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
Medicine Products: